Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Pregnancy and Childbirth
Published in: BMC Pregnancy and Childbirth 1/2014

Open Access 01-12-2014 | Research article

Factors affecting the uptake of prenatal screening tests for congenital anomalies; a multicentre prospective cohort study

Authors: Janneke T Gitsels - van der Wal, Pieternel S Verhoeven, Judith Manniën, Linda Martin, Hans S Reinders, Evelien Spelten, Eileen K Hutton

Published in: BMC Pregnancy and Childbirth | Issue 1/2014

Login to get access

Abstract

Background

Two prenatal screening tests for congenital anomalies are offered to all pregnant women in the Netherlands on an opt-in basis: the Combined Test (CT) for Down syndrome at twelve weeks, and the Fetal Anomaly Scan (FAS) at around twenty weeks. The CT is free for women who are 36 or older; the FAS is free for all women. We investigated factors associated with the CT and FAS uptake.

Method

This study is part of the DELIVER study that evaluated primary care midwifery in the Netherlands. Associations between the women’s characteristics and the CT and FAS uptake were measured using multivariate and multilevel logistic regression analyses.

Results

Of 5216 participants, 23% had the CT and 90% had the FAS, with uptake rates ranging from 4% to 48% and 62% to 98% respectively between practices. Age (OR: 2.71), income (OR: 1.38), ethnicity (OR: 1.37), being Protestant (OR: 0.25), multiparous (OR: 0.64) and living in the east of the country (OR: 0.31) were associated with CT uptake; education (OR: 1.26), income (OR: 1.66), being Protestant (OR: 0.37) or Muslim (OR: 0.31) and being multiparous (OR: 0.74) were associated with FAS uptake. Among western women with a non-Dutch background, first generation (OR: 2.91), age (OR: 2.00), income (OR: 1.97), being Protestant (OR: 0.32) and living in the east (OR: 0.44) were associated with CT uptake; being Catholic (OR: 0.27), Protestant (OR: 0.13) were associated with FAS uptake. Among non- western women with a non-Dutch background, age (OR: 1.73), income (OR: 1.97) and lacking proficiency in Dutch (OR: 2.18) were associated with CT uptake; higher education (OR: 1.47), being Muslim (OR: 0.37) and first generation (OR: 0.27) were associated with FAS uptake.

Conclusion

The uptake of the CT and FAS varied widely between practices. Income, parity and being Protestant were associated with uptake of both tests; ethnicity, age and living in the east were associated with CT uptake, and education and being Muslim with FAS uptake. These findings help to explain some differences between women choosing or declining early and late screening, but not the large variation in test uptake among practices, nor between the Netherlands and other countries.
Literature
1.
Ward P: Down’s Syndrome Screening in England. 2011, London: NHS Fetal Anomaly Screening Programme. Committee UNS
2.
Ekelund CK, Petersen OB, Skibsted L, Kjaergaard S, Vogel I, Tabor A: First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13. Ultrasound Obstet Gynecol. 2011, 38: 140-144.CrossRefPubMed
3.
Jakobsen TR, Sogaard K, Tabor A: Implications of a first trimester Down syndrome screening program on timing of malformation detection. Acta Obstet Gynecol Scand. 2011, 90: 728-736.CrossRefPubMed
4.
Gottfredsdottir H, Bjornsdottir K, Sandall J: How do prospective parents who decline prenatal screening account for their decision? A qualitative study. Soc Sci Med. 2009, 69: 274-277.CrossRefPubMed
5.
Bosch M, Adriaanse C, Ter ME, van der Ven J: Results of prenatal screening 2008 in nine primary care ultrasound centra. (in Dutch). Tijdschrift voor Verloskundigen. 2010, 6: 45-50.
6.
Fracheboud J, van Agt HME, de Koning HJ: Monitoring 2009 of Prenatal Screening for Down’s Syndrome and for Foetal Anomalies in the Netherlands. 2011, Bilthoven: Final Report RIVM
7.
Schielen PCJI: Quality Control Parameters of Dutch Down’s Syndrome Screening Laboratories 2010. 2012, Bilthoven: RIVM Report 230083003
8.
Bakker M, Birnie E, Pajkrt E, Bilardo CM, Snijders RJM: Low uptake of the combined test in The Netherlands–which factors contribute?. Prenat Diagn. 2012, 32: 1305-1312.CrossRefPubMed
9.
Georgsson Öhman S, Waldenstrom U: Second-trimester routine ultrasound screening: expectations and experiences in a nationwide Swedish sample. Ultrasound Obstet Gynecol. 2008, 32: 15-22.CrossRefPubMed
10.
Van den Berg M, Timmermans DRM, Kleinveld JH, Garcia E, van Vugt JMG, van der Wal G: Accepting of declining the offer of prenatal screening for congenital defects: test uptake and women’s reasons. Prenat Diagn. 2005, 25: 84-90.CrossRefPubMed
11.
Ahmed S, Atkin K, Hewison J, Green J: The influence of faith and religion and the role of religious and community leaders in prenatal decisions for sickle cell disorders and thalassaemia major. Prenat Diagn. 2005, 26: 801-809.CrossRef
12.
Fransen MP, Essink-Bot ML, Oenema A, Mackenbach JP, Steegers EAP, Wildschut HIJ: Ethnic differences in determinants of participation and non-participation in prenatal screening for down-syndrome: a theoretical framework. Prenat Diagn. 2007, 27: 938-950.CrossRefPubMed
13.
Fransen MH, de Koning HJ, Lausy JA, Galjaard RJ, Looman CW, Essink-Bot ML, Wildschut HJ: Ethnic differences in participation in prenatal screening for Down syndrome: a register-based study. Prenat Diagn. 2010, 30: 988-994.CrossRefPubMed
14.
Seror V, Ville Y: Prenatal screening for Down syndrome: women’s involvement in decision-making and their attitudes to screening. Prenat Diagn. 2009, 29: 120-128.CrossRefPubMed
15.
Maxwell S, Brameld K, Bower C, Dichinson JE, Godblatt J, Hadlow N, Hewitt B, Murch A, Murphy A, Stock R, O’Leary P: Socio-demographic disparities in the uptake of prenatal screening and diagnosis in Western Australia. Aust N Z J Obstet Gynaecol. 2011, 51: 9-16.CrossRefPubMed
16.
Tischler R, Hudgins L, Blumenfeld YJ, Greely HT, Ormond KE: Noninvasive prenatal diagnosis: pregnant women’s interest and expected uptake. Prenat Diagn. 2011, 31: 1292-1299.CrossRefPubMedPubMedCentral
17.
Yu JA: Systematic review of issues around antenatal screening and prenatal diagnostic testing for genetic disorders: women of Asian origin in western countries. Health & Social Care Community. 2012, 20: 329-346.CrossRef
18.
der Wal JT G-v, Manniën J, Ghaly MM, Verhoeven PS, Hutton EK, Reinders JS: The role of religion in decision-making on prenatal screening of congenital anomalies: a qualitative study amongst Muslim Turkish origin immigrants. Midwifery. 2014, 30 (3): 297-302.CrossRef
19.
Garcia E, Timmermans DRM, van Leeuwen E: The impact of ethical beliefs on decisions about prenatal screening tests: searching for justification. Soc Sci Med. 2008, 66: 753-764.CrossRefPubMed
20.
21.
Alderliesten ME, Stronks K, van Lith JM, Smit BJ, van der Wal MF, Bonsel GJ, Bleker OP: Ethnic differences in perinatal mortality. A perinatal audit on the role of substandard care. Eur J Obstet Gynecol Reprod Biol. 2008, 138 (2): 164-170.CrossRefPubMed
22.
Choté AA, de Groot CJ, Bruijnzeels MA, Redekop K, Jaddoe VW, Steegers EA, Mackenbach JP, Foets M: Ethnic differences in antenatal care use in a large multi-ethnic urban population in the Netherlands. Midwifery. 2011, 27: 36-41.CrossRefPubMed
23.
Wiegers TA: The quality of maternity care services as experienced by women in the Netherlands. BMC Pregn Childbirth. 2009, 9: 9-18.CrossRef
24.
Manniën J, Klomp T, Wiegers T, Pereboom M, Brug J, Jong A, van der Meijde M, Hutton E, Schellevis F, Spelten E: Evaluation of primary care midwifery in the Netherlands: design and rationale of a dynamic cohort study (DELIVER). BMC Health Serv Res. 2012, 12: 69-79.CrossRefPubMedPubMedCentral
25.
26.
27.
28.
29.
Martin L, van Dulmen S, Spelten E, de Jonge A, de Cock P, Hutton E: Prenatal counseling for congenital anomaly tests: parental preferences and perceptions of midwife performance. Prenat Diagn. 2013, 33: 1-12.CrossRef
30.
de Graaf G, van Os C, Borstlap R, de Graaf E: Parents’ experiences with prenatal screening. (in Dutch). Down+Up. 2010, 91: 37-48.
31.
32.
33.
Schoonen HMHJ, Essink-Bot ML, van Agt HM, Wildshut HI, Steegers EA, de Koning HJ: Informed decision-making about the fetal anomaly scan: what knowledge is relevant?. Ultrasound Obstet Gynecol. 2011, 27 (6): 649-657.CrossRef
34.
Molander E, Alehagen S, Berterö CM: Routine ultrasound examination during pregnancy: a world of possibilities Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination. Midwifery. 2010, 26 (1): 18-26.CrossRefPubMed
35.
36.
Nakling J, Backe B: Adverse obstetric outcome in fetuses that are smaller than expected at second trimester routine ultrasound examination. Acta Obstet Gynecol Scand. 2002, 81: 846-851.CrossRefPubMed
37.
Bienstock JL, Holcroft CJ, Althaus J: Small fetal abdominal circumference in the second trimester and subsequent low maternal plasma glucose after a glucose challenge test is associated with the delivery of a small-for-gestational age neonate. Ultrasound Obstet Gynecol. 2008, 31: 517-519.CrossRefPubMed
38.
Kofinas A, Kofinas G, Sutija V: The role of second trimester ultrasound in the diagnosis of placental hypoechoic lesions leading to poor pregnancy outcome. J Matern Fetal Med. 2008, 20 (12): 859-866.CrossRef
39.
Gardosi J, Maduransinghe V, Williams M, Mailk A, Francis A: Maternal and fetal risk factors for stillbirth: population based study. BMJ. 2013, 346: f108-CrossRefPubMedPubMedCentral
40.
Liu S, Joseph KS, Kramer MS, Allen AC, Sauve R, Rusen ID, Wen SW: Relationship of prenatal diagnosis and pregnancy termination to overall infant mortality in Canada. JAMA. 2002, 287 (12): 1561-1567.CrossRefPubMed
41.
42.
Fransen MP, Essink-Bot ML, Vogel I, Mackenbach JP, Steegers EA, Wildschut HI: Ethnic differences in informed decision-making about prenatal screening for Down’s syndrome. J Epidemiol Community Health. 2010, 64 (3): 262-268.CrossRefPubMed
43.
El-Hashemite N: Genetic Malformation in Children, its Causes, and the Islamic View in Preventive Procedures. 1995, London: Dar Al-Hekma, 105-131.
44.
Albar MA: Ethical considerations in the prevention and management of genetic disorders with special emphasis on religious considerations. Saudi Med J. 2002, 23: 627-632.PubMed
45.
Metadata
Title
Factors affecting the uptake of prenatal screening tests for congenital anomalies; a multicentre prospective cohort study
Authors
Janneke T Gitsels - van der Wal
Pieternel S Verhoeven
Judith Manniën
Linda Martin
Hans S Reinders
Evelien Spelten
Eileen K Hutton
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2014
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/1471-2393-14-264

Other articles of this Issue 1/2014

BMC Pregnancy and Childbirth 1/2014 Go to the issue

Research article

What factors explain pregnant women’s feeding intentions in Bradford, England: A multi-methods, multi-ethnic study

Research article

Opportunities and challenges in implementing community based skilled birth attendance strategy in Kenya

Study protocol

Supporting breastfeeding In Local Communities (SILC): protocol for a cluster randomised controlled trial

Research article

Psychological violence against pregnant women in a prenatal care cohort: rates and associated factors in São Luís, Brazil

Research article

Cross sectional study in China: fetal gender has adverse perinatal outcomes in mainland China

Research article

Use of a DVD to provide dietary and lifestyle information to pregnant women who are overweight or obese: a nested randomised trial